RNAi News: Innovative Newsletter to Focus on RNA Interference, New Tool For Functional Genomics and Drug Discovery
NEW YORK, Sept. 10 /PRNewswire/ -- A weekly newsletter covering an important new life sciences research technology published its first issue this week. RNAi News is the first publication to focus on the field of RNA interference, a pioneering tool for studying gene function and developing new drugs.
RNAi News is the latest application-focus newsletter from GenomeWeb LLC, a New York-based information provider serving the life science research community. Charter subscribers to the new publication include major biomedical research institutions, biotechnology companies, suppliers of RNAi tools and systems, and investment firms that follow the industry.
The debut issue of RNAi News is available for free download at rnainews.com.
RNAi News is edited by Doug Macron, a veteran biotechnology journalist who recently joined GenomeWeb from Reuters Health. Contact him at mail to: dmacron@genomeweb.com
About GenomeWeb LLC
GenomeWeb is a leading provider of news and information to scientists and technologists pursuing advanced research in genomics, proteomics, bioinformatics and drug discovery. In addition to RNAi News, it publishes the weekly application-focus newsletters ProteoMonitor, BioArray News, BioInform, and SNPtech Reporter.
GenomeWeb also publishes the monthly magazine Genome Technology -- which published its own groundbreaking four-part series on RNA interference this summer -- and GenomeWeb Daily News, providing continuous technology and research news throughout the business day.
SOURCE GenomeWeb LLC
CO: GenomeWeb LLC
ST: New York
SU: PDT
Web site: genomeweb.com
prnewswire.com
09/10/2003 11:04 EDT |
